"We got really lucky about six years ago when we started exploring how cannabinoids might be used to treat drug-resistant infections," says Dr. Dana Lambert, CEO of Andira Pharmaceuticals, in an exclusive interview with Benzinga.
Dr. Lambert doesn't speak like an academic. Despite holding a Ph.D. in pharmaceutical sciences, she talks like someone who has witnessed medicine fail firsthand. She began her career as a hospital pharmacist, working with critically ill patients — people battling cancer, severe infections and other conditions where existing treatments often fell short.